Cagdas Baran

Prof. Dr. Cagdas Baran

Cardiovascular Surgery, Ankara University, Ankara, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2011 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
Cagdas BaranCagdas Baran
Cagdas Baran
SDSerkan Durdu
Serkan Durdu
KDKlara Dalva
Klara Dalva
ÇZÇagın Zaim
Çagın Zaim
ADArın Dogan
Arın Dogan
AAAhmet Ruchan Akar
Ahmet Ruchan Akar

2 March 2015 in EP Europace
Verified
Journal Article
Open access
PDF file
GPGiuseppe Patti
Giuseppe Patti
RBRachel Bennett
Rachel Bennett
SSSreenivasa Rao Kondapally Seshasai
Sreenivasa Rao Kondapally Seshasai
CCChristopher P. Cannon
Christopher P. Cannon
ICIlaria Cavallari
Ilaria Cavallari
KRKausik K. Ray
Kausik K. Ray
Statin pretreatment in patients undergoing cardiac surgery is understood to prevent postoperative atrial fibrillation (AF). However, this is based on observational and limited randomized trial evidence, resulting in uncertainty about any genuine anti-arrhythmic benefits of these agents in this setting. We therefore aimed to quantify precisely the association between statin pretreatment and postoperative AF among patients undergoing cardiac surgery. A detailed search of MEDLINE and PubMed databases (1st January 1996 to 31st July 2012) was conducted, followed by a review of the reference lists of published studies and correspondence with trial investigators to obtain individual–participant data for meta-analysis. Evidence was combined across prospective, randomized clinical trials that compared the risk of postoperative AF among individuals randomized to statin pretreatment or placebo/control medication before elective cardiac surgery. Postoperative AF was defined as episodes of AF lasting ≥5 min. Overall, 1105 participants from 11 trials were included; of them, 552 received statin therapy preoperatively. Postoperative AF occurred in 19% of these participants when compared with 36% of those not treated with statins (odds ratio 0.41, 95% confidence interval 0.31–0.54, P < 0.00001, using a random-effects model). Atrial fibrillation prevention by statin pretreatment was consistent across different subgroups. Short-term statin pretreatment may reduce the risk of postoperative AF among patients undergoing cardiac surgery.

1 June 2018 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
Cagdas BaranCagdas Baran
Cagdas Baran
MDMustafa Serkan Durdu
Mustafa Serkan Durdu
FGFatih Gumus
Fatih Gumus
MCMehmet Cakici
Mehmet Cakici
MIMustafa Bahadir Inan
Mustafa Bahadir Inan
AAAhmet Ruchan Akar
Ahmet Ruchan Akar

30 August 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
TKTANIL KENDIRLI
TANIL KENDIRLI
SÖSerhan Özcan
Serhan Özcan
MHMERVE HAVAN
MERVE HAVAN
Cagdas BaranCagdas Baran
Cagdas Baran
MÇMehmet Çakici
Mehmet Çakici
AAAhmet Ruchan Akar
Ahmet Ruchan Akar
Extracorporeal cardiopulmonary resuscitation (ECPR) is defined as the veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support in a patient who experienced a sudden pulseless condition attributable to cessation of cardiac mechanical activity and circulation. We aimed to evaluate the clinical outcomes of our ECPR experience in a pediatric patient population. Between September 2014 and November 2017, fifteen children were supported with ECPR following in-hospital cardiac arrest (IHCA) in our hospitals. VA-ECMO setting was established for all patients. Pediatric cerebral performance category (PCPC) scales and long-term neurological prognosis of the survivors were assessed. The median age of the study population was 60 (4-156) months. The median weight was 18 (4.8-145) kg, height was 115 (63-172) cm, and body surface area was 0.73 (0.27-2.49) m2. The cause of cardiac arrest was a cardiac and circulatory failure in 12 patients (80%) and non-cardiac in 20%. Dysrhythmia was present in 46%, septic shock in 13%, bleeding in 6%, low cardiac output syndrome in 13%, and airway disease in 6% of the study population. Median low-flow time was 95 (range 20-320) minutes. Central VA-ECMO cannulation was placed in only 2 (13.3%) cases. However, the return of spontaneous circulation (ROSC) was obtained in 10 (66.6%) patients, and 5 (50%) of them survived. Overall, five patients discharged from the hospital. Finally, survival following ECPR was 33.3%, and all survivors were neurologically intact at hospital-discharge. ECPR can be a life-saving therapeutic strategy using a promising technology in the pediatric IHCA population. For better survival rates, early initiation, well-coordinated, skilled, and dedicated ECMO team is the mainstay.

13 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Cagdas BaranCagdas Baran
Cagdas Baran
AKAhmet Kayan
Ahmet Kayan
CBCanan Soykan Baran
Canan Soykan Baran
Objective: Massive pulmonary embolism (PE) remains a life-threatening condition, often leading to acute respiratory and cardiac failure. This study evaluates the role of extracorporeal membrane oxygenation (ECMO) as a supportive treatment for high-risk patients undergoing surgical pulmonary embolectomy or catheter-based thrombectomy. Methods: Between January 2018 and December 2023, 27 patients with high-risk massive PE were treated at our center. Surgical embolectomy (n = 7) and catheter-based thrombectomy (n = 5) were performed, with ECMO support (veno-arterial [VA] or veno-arterial-venous [VAV]) initiated preoperatively, intraoperatively, or postoperatively, based on hemodynamic instability. ECMO was used as a bridge to recovery, and outcomes were assessed in terms of mortality, hemodynamic stabilization, and recovery. Results: Of the 27 patients, 20 were supported with ECMO, with 7 requiring VA-ECMO intraoperatively due to difficulties in weaning from cardiopulmonary bypass (CPB). Nine patients were later transitioned to VAV-ECMO due to Harlequin syndrome and persistent hemodynamic instability. The in-hospital mortality rate was 18.5% (n = 5), with survivors showing significant improvements in hemodynamic and biochemical parameters post-ECMO, including reduced lactate levels, improved right ventricular function, and the stabilization of mean arterial pressure. The mean follow-up time was 10.2 ± 3.9 months, with no late deaths or complications observed. Conclusions: ECMO provides effective life support in high-risk patients with massive PE who are undergoing surgical embolectomy or thrombectomy. It stabilizes hemodynamics, improves cardiac and pulmonary function, and facilitates recovery in critically ill patients. Further research is needed to refine patient selection, optimize ECMO timing, and assess long-term outcomes to determine its definitive role in the management of high-risk PE.

26 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EÖEvren Özçınar
Evren Özçınar
NDNur Dikmen
Nur Dikmen
Cagdas BaranCagdas Baran
Cagdas Baran
OBOnur Buyukcakir
Onur Buyukcakir
MKMelisa Kandemir
Melisa Kandemir
LYLevent Yazicioglu
Levent Yazicioglu
Background: Thoracic endovascular aortic repair (TEVAR) has become the first-line therapy for descending aortic disease. Recent studies have demonstrated that preventive revascularization of the left subclavian artery (LSA) in zone 2 TEVAR cases reduces the risk of neurological complications. However, there is no uniform consensus on the choice of revascularization techniques. Although carotid-subclavian bypass is considered the gold standard method, in situ fenestration techniques have also shown encouraging results. This study aims to compare the carotid-LSA bypass with in situ fenestration (ISF) for LSA revascularization and to discuss our treatment approach. Methods: We conducted a retrospective review of all patients undergoing zone 2 TEVAR with in situ fenestration (ISF) or carotid-subclavian artery bypasses for LSA revascularization at our institution between February 2011 and February 2024. Preoperative patient characteristics and primary outcomes, such as operative mortality, transient ischemic attack, stroke, and spinal cord ischemia, were analyzed between the groups. Results: During the 13-year study period, 185 patients underwent TEVAR procedures. Of these, 51 patients had LSA revascularization with zone 2 TEVAR; 32 patients underwent carotid-subclavian artery bypasses, and 19 underwent in situ fenestration. The technical success rate was 100%. Statistically, there was no significant difference between the groups in terms of primary outcomes such as stroke, transient ischemic attack, spinal cord ischemia, and death (p > 0.05). Conclusions: In situ fenestration (ISF) may be an effective and feasible method for LSA revascularization. With precise patient selection and in experienced hands, ISF appears to be associated with similar perioperative outcomes and mortality rates to the carotid-subclavian bypass.